The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
South West; Gloucestershire; Wiltshire and North Somerset
Location of affected unit(s)
Avonmouth
Sector
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
270 jobs Number of planned job losses
Announcement Date
15 February 2019
Employment effect (start)
Foreseen end date
30 April 2019
Description
Avara Avlon Pharma based in Avonmouth, Bristol has announced that it is entering administration placing all 270 jobs at risk of redundancy. The decision comes after a major contract has ended, leaving the company in a difficult financial position. The business which was part of the AstraZeneca group until 2016 has agreed a deal with the former owners which will keep the business open until the end of March 2019. However, if no buyer is found for the company and its assets, then all 270 jobs will be made redundant in April 2019.
Eurofound (2019), Avara Avlon Pharma Services, Bankruptcy in United Kingdom, factsheet number 97322, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/97322.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
